Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

Groundbreaking First-in-Human Study Demonstrates Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells Without ...
Fierce Biotech

Sana sees 14-month insulin production for transplanted islet therapy in single Type 1 diabetes patient

In a 14-month follow-up, Sana Biotechnology has found that its investigational allogeneic cell therapy continued to produce insulin in one patient with Type 1 diabetes, with no safety concerns ...
Fitgurú on MSN

Think twice before taking these 2 supplements if you have diabetes

Some supplements promise health benefits, but experts warn that certain products may interfere with medications or affect blood sugar control in people living with diabetes.
ascopubs.org

Insulin resistance and impaired insulin secretion and gastrointestinal cancer risk in Korean adults: Preliminary results from Korean Genome and Epidemiology study.

Single cell transcriptomic profiling of appendiceal adenocarcinoma to identify rare tumor cells and a myeloid-enriched tumor microenvironment (TME). This is an ASCO Meeting Abstract from the 2024 ASCO ...

PolTREG moves forward with the European registration process for TREG therapy in type 1 diabetes

The European Medicines Agency (EMA) has officially qualified PolTREG to submit an application for marketing authorization in the European Union for the PolTREG-T1D cell preparation. GDAŃSK, Poland, ...

How do GLP-1 agonists affect gene expression?

GLP-1s are building a reputation as "wonder drugs." First characterized for their ability to improve insulin release and treat diabetes, the drugs were later found to promote weight loss and improve ...